# Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

> **NCT01106495** · NA · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 150 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DEVICE:** Enhanced External Counterpulsation (EECP)
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01106495
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2018-10
- **Final completion:** 2020-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106495, "Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01106495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*